Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)
China · Delayed Price · Currency is CNY 18.08
+0.92 (5.36%)
Feb 3, 2026, 3:04 PM CST
SHE:300401 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 301.8 | 309.21 | 192.35 | 383.72 | 483.77 | 263.22 |
Depreciation & Amortization | 155.59 | 155.59 | 133.36 | 60.98 | 44.59 | 45.66 |
Other Amortization | 0.25 | 0.25 | - | - | - | - |
Loss (Gain) From Sale of Assets | -31.53 | -31.53 | 0.04 | -17.8 | -76.22 | -0.02 |
Asset Writedown & Restructuring Costs | 0.19 | 0.19 | 0.28 | 1.01 | 0.09 | 0.88 |
Loss (Gain) From Sale of Investments | -0.72 | -0.72 | 0.27 | -1.45 | -4.63 | -5.56 |
Provision & Write-off of Bad Debts | 1.97 | 1.97 | -2.39 | 2.53 | 0.32 | 0.04 |
Other Operating Activities | 114.67 | 33.82 | 52.57 | 20.43 | 41.35 | 16.03 |
Change in Accounts Receivable | -35.7 | -35.7 | 113.38 | -140.76 | -47.29 | 9.94 |
Change in Inventory | -60.38 | -60.38 | -234.77 | -116.05 | -106.11 | -5.59 |
Change in Accounts Payable | 77.37 | 77.37 | -98.6 | 184.45 | 165.15 | 94.58 |
Change in Other Net Operating Assets | 20.51 | 20.51 | 28.78 | 7.91 | 0.82 | 23.58 |
Operating Cash Flow | 539.84 | 466.41 | 159.98 | 377.04 | 512.25 | 427.41 |
Operating Cash Flow Growth | 64.43% | 191.53% | -57.57% | -26.40% | 19.85% | 16.61% |
Capital Expenditures | -436.55 | -480.38 | -244.55 | -379.93 | -715.58 | -593.87 |
Sale of Property, Plant & Equipment | 10.92 | 29.31 | 0.68 | 12.52 | 114.44 | 80.06 |
Cash Acquisitions | -93.33 | -93.33 | -93.33 | - | -790.01 | - |
Investment in Securities | 30 | -140 | 24.16 | -0.08 | 200 | -99.7 |
Other Investing Activities | 4.1 | -9.78 | -31.43 | -4.67 | 4.63 | 5.56 |
Investing Cash Flow | -484.87 | -694.18 | -344.47 | -372.15 | -1,186 | -607.94 |
Short-Term Debt Issued | - | - | - | 933.58 | 493.37 | 472.86 |
Long-Term Debt Issued | - | 1,226 | 2,285 | - | - | - |
Total Debt Issued | 977.1 | 1,226 | 2,285 | 933.58 | 493.37 | 472.86 |
Short-Term Debt Repaid | - | - | - | -818.35 | -414.45 | -401.79 |
Long-Term Debt Repaid | - | -1,138 | -962.97 | - | -0.19 | - |
Total Debt Repaid | -800.81 | -1,138 | -962.97 | -818.35 | -414.64 | -401.79 |
Net Debt Issued (Repaid) | 176.29 | 87.62 | 1,322 | 115.23 | 78.72 | 71.06 |
Issuance of Common Stock | - | - | - | 53.72 | 3.5 | 894.51 |
Repurchase of Common Stock | -13.27 | -13.27 | -86.74 | - | - | - |
Common Dividends Paid | -91.78 | -67.39 | -103.08 | -122.74 | -65.99 | -10.08 |
Other Financing Activities | 12.43 | 100.7 | -92.3 | -2.23 | -28.77 | -119.61 |
Financing Cash Flow | 83.67 | 107.66 | 1,040 | 43.99 | -12.53 | 835.89 |
Foreign Exchange Rate Adjustments | 4.53 | 4.15 | 3.47 | 1.91 | -1.43 | -2.49 |
Net Cash Flow | 143.18 | -115.97 | 859.32 | 50.79 | -687.57 | 652.86 |
Free Cash Flow | 103.29 | -13.97 | -84.57 | -2.89 | -203.33 | -166.46 |
Free Cash Flow Margin | 8.32% | -1.12% | -7.72% | -0.20% | -18.20% | -25.24% |
Free Cash Flow Per Share | 0.18 | -0.02 | -0.14 | -0.01 | -0.37 | -0.33 |
Cash Income Tax Paid | - | 54.3 | 3.08 | 81.87 | 76.06 | -9.76 |
Levered Free Cash Flow | 66.3 | -201.29 | -303.71 | -6.59 | -426.66 | -180.45 |
Unlevered Free Cash Flow | 85.67 | -179.01 | -279.7 | 7.05 | -419.9 | -169.89 |
Change in Working Capital | -2.38 | -2.38 | -216.5 | -72.39 | 22.98 | 107.17 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.